Video

Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC

Izalontamab brenitecan shows promising activity in previously treated EGFR mutated NSCLC

13 October 2026
Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia

Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia

13 October 2026
Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

13 October 2026
FinCan: Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India

Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India

12 October 2026
Provider perceptions of “adapted” regimens may influence childhood cancer guideline uptake

Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines

12 October 2026
Blinatumomab implementation in LMICs highlights barriers and facilitators to equitable access

Multilevel factors shaping blinatumomab delivery across diverse LMICs

12 October 2026
Building the cancer system of the future in UAE

Building the cancer system of the future in UAE

9 October 2026
Equitable HPV vaccination for all

Equitable HPV vaccination for all

9 October 2026
Designing around lives: A decentralised, people-centred oncology care architecture from India

Designing around lives: A decentralised, people-centred oncology care architecture from India

9 October 2026
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

8 October 2026
Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

Isa-VRd shows sustained benefit in transplant-ineligible newly diagnosed multiple myeloma

7 October 2026
Using artificial intelligence to improve lung cancer screening and risk prediction

Using artificial intelligence to improve lung cancer screening and risk prediction

6 October 2026
Back to Top